FDA-approved colorectal cancer blood test offers easier alternative to colonoscopies, doctor says

Dr. Trisha Pasricha joins 'Fox & Friends' to sermon the FDA's support of a caller humor trial designed to observe colorectal crab early. She explains the rising rates among younger adults and the value of screening.

Harvard Medical School adjunct prof Dr. Trisha Pasricha discusses a recently FDA-approved humor trial designed to observe colorectal crab aboriginal with Ainsley Earhardt. Pasricha explains however this instrumentality detects early-stage illness and addresses wherefore colon crab rates are rising importantly among adults nether 50, urging eligible Americans to not skip regular screenings.